Sabuwar tafiya ta sauye-sauyen dijital | Hongjitang Pharmaceutical da Sinovate sun haɗu don ƙaddamar da aikin LIMS
A safiyar ranar 3 ga Satumba, an fara taron farko na Hongjitang An gudanar da aikin Pharmaceutical LIMS (Daraktan Bayanai Tsarin Gudanar da Bayanai) cikin nasara cikin yanayi mai dumi. Yan Rui, Mataimakin Shugaban Kamfanin Sinovate Technology Co., Ltd., Wu Youmao, Daraktan Ayyuka, Zhang Ran, Shugaban Kamfanin Hongjitang Pharmaceutical, Liu Xingcun, Mataimakin Shugaban Kasa, Liu Cejia, da sauran manyan shugabanni da manyan membobin aikin sun halarci taron ƙaddamar da aikin, wanda ya nuna muhimmin matakin haɗin gwiwa tsakanin ɓangarorin biyu.


Kaddamar da Aiki: Muhimmin Ci gaba a Canjin Dijital
A farkon taron, Liu Cejia, Mataimakin Shugaban Kamfanin Hongjitang Pharmaceutical, ya gabatar da cikakken bayani game da asali da mahimmancin aikin LIMS. Ya nuna cewa a ƙarƙashin buƙatun masana'antu da haɓaka kamfanoni, Hongjitang Pharmaceutical tana shirin tsara tsarin canjin dijital tun daga 2021, da nufin inganta ingantaccen aiki da matakin gudanarwa ta hanyar hanyoyin fasaha. Bayan tattaunawa mai zurfi da tattaunawa, Hongjitang Pharmaceutical da Sinovac sun haɗu don ƙaddamar da aikin LIMS, wanda hakan ya nuna muhimmin mataki a cikin sauya hanyoyin kasuwanci na gargajiya zuwa ga hankali.

Rahoton Aiki: Hanyar Aiwatarwa Mai Tsari
Daga baya, Wu Youmao, darektan ayyukan Sinovate, ya bayar da cikakken rahoto mai zurfi game da aikin LIMS. Ya yi bayani dalla-dalla kan tsarin tsare-tsare da aiwatar da aikin LIMS daga fannoni daban-daban, ciki har da matsayin kasuwanci, nazarin wuraren da ke da zafi, manufofin gini, tsarin fasaha, da dabarun aiwatarwa. Mista Wu ya jaddada cewa aikin zai bi ka'idodin manyan ka'idoji da buƙatu masu tsauri, yana tabbatar da cewa kowane mataki yana da ƙarfi da tasiri, tare da samar da goyon baya mai ƙarfi ga sauyin dijital na Hongjitang Pharmaceutical.

Shawarar sharhi: Sauƙi da daidaitawa sune mahimmanci
Game da rahoton Mr. Wu, Liu Xingcun, Mataimakin Shugaban Kamfanin Hongjitang Pharmaceutical, ya ba da yabo da shawarwari masu mahimmanci. Ya jaddada cewa mabuɗin nasarar aikin yana cikin tsari mai kyau da aiwatarwa mai inganci. Ya gabatar da "Ka'idoji Bakwai" - masu sassaucin ra'ayi, masu daidaito, masu sarrafa kansu, ta yanar gizo, masu tushen bayanai, masu gani, da kuma masu daidaita darajar aiki, wanda ke buƙatar ƙungiyoyin ayyuka su bi waɗannan ƙa'idodi sosai yayin aiwatarwa don tabbatar da aiwatarwa cikin sauƙi da fa'idodin aikin.

Hannu da Hannu: Ƙirƙirar Makoma Mai Kyau Tare
Yan Rui, Mataimakiyar Shugabar Sinovate, ta yarda da shawarar Mr. Liu sosai kuma ta raba babban motsin zuciyarta game da Hongjitang Pharmaceuticals da al'adun gargajiya na maganin gargajiya na kasar Sin. Ta yi alƙawarin jagorantar ƙungiyar da kanta, da kuma kula da ci gaban aikin, da kuma tabbatar da aiwatar da shi cikin sauƙi. A lokaci guda kuma, ta gabatar da shawarwari kamar manufofin ƙarfafa ma'aikata, tana fatan ɓangarorin biyu za su iya yin aiki tare don ƙirƙirar kyakkyawar makoma.

Jawabin Takaitawa: Bin gaskiya da kirkire-kirkire, wanda ke jagorantar ci gaban masana'antar
A ƙarshe, Zhang Ran, Shugaban Kamfanin Hongjitang Pharmaceutical, ya gabatar da jawabin ƙarshe. Ya jaddada cewa a matsayinsa na kamfani mai daraja na ƙarni na ƙasar Sin, Hongjitang Pharmaceutical zai ci gaba da riƙe manufar gado da kirkire-kirkire, tare da ci gaba da haɓaka ci gaban zamani na maganin gargajiya na ƙasar Sin. Ƙungiyar inganci ta Hongjitang Pharmaceutical tana da niyyar karya tsarin gargajiya, mai da hankali kan makomar, kiyaye mutunci da kirkire-kirkire, da kuma bai wa kamfanin fasahar zamani ta ƙarni. Haɗin gwiwa da Sinovate muhimmin mataki ne a cikin sauyin dijital na Hongjitang Pharmaceutical kuma muhimmin ginshiƙi ga ci gaban kamfanin a nan gaba. Yana sa ran ɓangarorin biyu za su iya ci gaba da zurfafa haɗin gwiwa, tare da bincika sabbin hanyoyin ci gaba mai hankali, da kuma gina Hongjitang Pharmaceutical a matsayin sabon ma'auni don haɓaka magungunan gargajiya na ƙasar Sin da kamfanonin shirye-shirye masu sauƙi, wanda ke ba da gudummawa ga sauye-sauyen dijital na masana'antar magungunan ƙasar Sin.

Dangane da zurfafa sadarwa da kuma karo na akida, Hongjitang Pharmaceutical ta gayyaci tawagar Sinovate da su ziyarci Masana'antar Masana'antu ta Laiwu da ke Laiwu Industrial Park. Wannan ziyarar ba wai kawai ta zurfafa fahimta da fahimtar shugabannin Sinovate game da hanyar ci gaban zamani ta Hongjitang Pharmaceutical ba, har ma ta kafa harsashi mai ƙarfi na goyon bayan bayanai masu amfani da kwarin gwiwa ga aikin LIMS mai zuwa.
Idan muka yi la'akari da makomar, Hongjitang Pharmaceutical da Sinovac za su ci gaba da aiki tare, suna dogara da fa'idodin sana'o'insu da ƙarfin albarkatu, don ƙirƙirar wani sabon ci gaba a cikin ci gaban fasahar zamani ta masana'antar magungunan gargajiya ta China. Dukansu za su himmatu wajen haɓaka haɗakar masana'antar magungunan gargajiya ta China da fasahar bayanai, wanda ke ƙarƙashin jagorancin fasaha da fasahar dijital, wanda ke jagorantar masana'antar magungunan gargajiya ta China zuwa ga wani kyakkyawan gobe!











